A recent study published in the Journal of Clinical Endocrinology & Metabolism suggests that consuming moderate amounts of coffee and caffeine regularly may offer protection against developing multiple cardiometabolic diseases. These diseases include type 2 diabetes, coronary heart disease, and stroke.
The research found that regular coffee or caffeine intake, especially at moderate levels, was associated with a lower risk of new-onset cardiometabolic multimorbidity (CM). CM refers to the coexistence of at least two cardiometabolic diseases.
As populations age globally, the prevalence of individuals with multiple cardiometabolic diseases is becoming a significant public health concern.
The study suggests that coffee and caffeine consumption could play a crucial role in preventing CM development.
According to lead author Chaofu Ke, consuming three cups of coffee or 200-300 mg of caffeine per day might reduce the risk of developing cardiometabolic multimorbidity in individuals without pre-existing cardiometabolic diseases.
The study analysed data from the UK Biobank, involving over 500,000 participants aged 37-73 years. The results showed that moderate coffee or caffeine consumers (200-300 mg/day) had a 48.1% or 40.7% reduced risk of new-onset CM compared to non-consumers or those consuming less than 100mg caffeine per day.
The study found that coffee and caffeine intake at all levels was inversely associated with the risk of new-onset CM in participants without cardiometabolic diseases. Moderate intake was linked to the lowest risk.
The findings suggest that promoting moderate coffee or caffeine consumption as a dietary habit among healthy individuals may have significant benefits for preventing cardiometabolic multimorbidity, according to Ke.
